Document Detail


A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma.
MedLine Citation:
PMID:  17348994     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of this study was to compare the efficacy and safety of a triple combination (TC) cream and monotherapy with hydroquinone (HQ) cream in the treatment of moderate to severe facial melasma. A total of 120 patients applied TC cream once daily or HQ cream twice daily for 8 weeks. Evaluations included static global severity assessment of melasma, improvement of melasma over time, local tolerability, and adverse events. TC cream was significantly more effective than HQ cream from week 4 onwards: lesions were approximately equivalent to the surrounding skin in 35% of all TC-treated patients, compared to 5% of those who used HQ cream (P = 0.0001). Improvement of more than 75% was achieved by 73% of TC cream patients and 49% of HQ cream patients (P = 0.007). The incidence of adverse events (erythema, burning sensation, and desquamation) was similar in both groups. No patient dropped out of the study because of drug-related adverse events. TC cream was more effective than the HQ cream for the treatment of moderate to severe facial melasma. Both products had similar safety profiles.
Authors:
Tania Ferreira Cestari; Karime Hassun; Alexandre Sittart; Maria de Lourdes Viegas
Related Documents :
7248174 - Dermatological non-disease: a common and potentially fatal disturbance of cutaneous bod...
19540674 - Macrophage migration inhibitory factor-a potential diagnostic tool in severe burn injur...
6328854 - Management of chemical eye injuries with prolonged irrigation.
20965664 - Rhabdomyolysis and acute renal failure in severely burned patients.
7867234 - Atrial fibrillation, transesophageal echo, electrical cardioversion, and anticoagulation.
8272754 - Haemostatic activation in patients with head injury with and without simultaneous multi...
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of cosmetic dermatology     Volume:  6     ISSN:  1473-2165     ISO Abbreviation:  J Cosmet Dermatol     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-03-12     Completed Date:  2007-03-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101130964     Medline TA:  J Cosmet Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  36-9     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Federal University of Rio Grande do Sul--Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil. tcestari@hcpa.ufrgs.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Adult
Drug Combinations
Emollients
Facial Dermatoses / diagnosis,  drug therapy*
Female
Fluocinolone Acetonide / therapeutic use*
Follow-Up Studies
Humans
Hydroquinones / administration & dosage*
Male
Melanosis / diagnosis,  drug therapy*
Middle Aged
Probability
Reference Values
Severity of Illness Index
Single-Blind Method
Treatment Outcome
Tretinoin / therapeutic use*
Chemical
Reg. No./Substance:
0/Drug Combinations; 0/Emollients; 0/Hydroquinones; 123-31-9/hydroquinone; 302-79-4/Tretinoin; 67-73-2/Fluocinolone Acetonide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparative benefit of two thermal spring waters after photodynamic therapy procedure.
Next Document:  Elderly skin and its rejuvenation: products and procedures for the aging skin.